98 related articles for article (PubMed ID: 20460884)
1. Immunology and liver disease/liver and metabolic syndrome. Preface.
Manns MP
Dig Dis; 2010; 28(1):5-6. PubMed ID: 20460884
[No Abstract] [Full Text] [Related]
2. Chemokines as immune mediators of liver diseases related to the metabolic syndrome.
Berres ML; Nellen A; Wasmuth HE
Dig Dis; 2010; 28(1):192-6. PubMed ID: 20460910
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.
Tsochatzis EA; Manolakopoulos S; Papatheodoridis GV; Archimandritis AJ
Scand J Gastroenterol; 2009; 44(1):6-14. PubMed ID: 18661429
[TBL] [Abstract][Full Text] [Related]
4. [Prospect of liver immunology: a report from the 59th Annual Meeting of the American Association for the study of liver diseases].
Yan WM; Ning Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):235-7. PubMed ID: 19335995
[No Abstract] [Full Text] [Related]
5. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
Tarantino G; Saldalamacchia G; Conca P; Arena A
J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
[TBL] [Abstract][Full Text] [Related]
6. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease and the metabolic syndrome.
Marchesini G; Babini M
Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and NASH.
Marchesini G; Marzocchi R
Clin Liver Dis; 2007 Feb; 11(1):105-17, ix. PubMed ID: 17544974
[TBL] [Abstract][Full Text] [Related]
9. [A liver-specific antigen in the serum of patients with liver disease].
Rosenmund A
Schweiz Med Wochenschr; 1971 Jul; 101(28):1023-6. PubMed ID: 5003908
[No Abstract] [Full Text] [Related]
10. Fatty liver: a novel component of the metabolic syndrome.
Kotronen A; Yki-Järvinen H
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):27-38. PubMed ID: 17690317
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
Younossi ZM; McCullough AJ
Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease as a feature of the metabolic syndrome.
Socha P; Wierzbicka A; Neuhoff-Murawska J; Włodarek D; Podleśny J; Socha J
Rocz Panstw Zakl Hig; 2007; 58(1):129-37. PubMed ID: 17711101
[TBL] [Abstract][Full Text] [Related]
13. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
Rafiq N; Younossi ZM
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome: relevant for all types of chronic liver diseases?
Marchesini G; Bianchi G
Gut; 2010 Oct; 59(10):1314-5. PubMed ID: 20833663
[No Abstract] [Full Text] [Related]
15. Fatty liver and the metabolic syndrome.
Neuschwander-Tetri BA
Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of liver-specific antigen in adult human serum.
Smith JB; Iverson GM
Clin Exp Immunol; 1973 Feb; 13(2):209-12. PubMed ID: 4120851
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
[TBL] [Abstract][Full Text] [Related]
18. [Strengthen the research and management of the relationship of liver diseases with metabolic syndrome].
Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):93-5. PubMed ID: 24000461
[No Abstract] [Full Text] [Related]
19. Metabolic syndrome--cardiovascular disease risk and more.
Carulli N
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():1-2. PubMed ID: 16225462
[No Abstract] [Full Text] [Related]
20. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
Rafiq N; Younossi ZM
Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
